Ferring Pharmaceuticals promotes Aaron Graff

Swiss biopharmaceutical company Ferring Pharmaceuticals has promoted Aaron Graff to chief commercial officer and executive vice president.

He was previously CEO of Ferring’s US operations and in his new role he will also sit on the Saint-Prex-based firm’s executive board.

Graff first joined Ferring in 2002 as VP of global marketing, business development and medical affairs, based in Copenhagen.

After leading the acquisition and integration of Israeli biopharmaceutical company BTG in 2005, he relocated his team to the newly established Ferring International Center in Saint-Prex.

He was then made senior VP, Asia region and global marketing, and since 2010 has led Ferring’s stateside operations from its US headquarters in New Jersey, first as chief operating officer and since 2016 as CEO.

Michel Pettigrew, president of Ferring Pharmaceuticals’ executive board and chief operating officer, said: “Under Aaron’s leadership in the United States, our US business grew at double-digit rates. His broad, global professional experience and track record make him uniquely qualified for this important role.”

Prior to joining Ferring, Graff worked at Bristol-Myers Squibb for over 17 years in a variety of sales, marketing and commercial operations management positions.